Malcolm Mccomas News Today

By Ben Glickman Pharmaxis will sell its mannitol respiratory business as part of a broader restructuring and pivot to focusing on treating blood-related...

Earlier this month, it took aim at BlackRock, the world’s largest asset manager, accusing it of poor portfolio management and corporate governance failures.

Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) has strengthened its board through the appointment of experienced life sciences investment professional Hashan De Silva...

Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) has appointed experienced senior global pharma executive Dr Simon Green to the Board of Directors as an independent...

Actinogen Medical is a biotech with a potentially "gazillion" dollar opportunity in its Alzheimer's drug

Pharmaxis might be two clinical studies away from rehabilitation, reports Tim Boreham

A Machiavellian plan to stop women joining the elite all-male club has led to broken friendships, high-profile resignations and divisions that have rippled across legal, business and political circles.

A Machiavellian plan to stop women joining the elite all-male club has led to broken friendships, high-profile resignations and divisions that have rippled across legal, business and political circles.

A Machiavellian plan to stop women joining the elite all-male club has led to broken friendships, high-profile resignations and divisions that have rippled across legal, business and political circles.

A Machiavellian plan to stop women joining the elite all-male club has led to broken friendships, high-profile resignations and divisions that have rippled across legal, business and political circles.